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Toward a Better Understanding of...
Parkinson’s Disease Fibrils: 
Analyzing Aggregation Growth Properties 
in a Cell System
María I. Dabrowski
Mentor: Paul T. Kotzbauer
Parkinson’s disease (PD) is the second most common neurodegenerative disease in the 
world. It occurs when neurons in the substantia nigra degenerate, leading to tremors, 
rigidity, slow muscle movement, and other physical and cognitive impairments. As of 
right now, there is no way to accurately diagnose PD prior to a post-mortem autopsy. 
In approximately less than 1% of PD patients, mutations in alpha-synuclein cause the 
protein to aggregate. There are five known mutations, and each cause slightly different 
aggregation outcomes depending on how the proteins misfold and clump together into 
fibrils. The purpose of our experiment is to generate these mutations in a cell system 
and test the cells to see how wild-type (WT) and mutated alpha-synuclein-expressing 
cells cause aggregation of the protein. Doing this in a cell system instead of in vitro will 
allow us to see how cellular lipids and proteins influence monomeric proteins to become 
integrated into fibrils, and how the aggregation properties differ across mutations. 
Additionally, completing experiments within a cell system will indicate what natural 
mechanisms cells have to remove or degrade monomers and fibrils, and how these 
removal pathways might be impacted by mutations. Studying the varying aggregation 
morphologies and growth patterns of these mutations will be a step in the right direction 
toward diagnosing PD and developing better treatments.
